MPLT vs ATXS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MPLT Captures Institutional Edge (2โ1 Pillars ยท 1โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MapLight Therapeutics, Inc. (MPLT) driven by superior Growth & Margin, Options & Structure while ATXS counters with relative strength in Momentum & Technical. Fundamentally, MPLT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ATXS at N/M Forward P/E and -4830.6% operating margin (+0.0% YoY). In options structure, MPLT sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against ATXS sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MPLT | ATXS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $392.9M | $713.6M | Larger Scale | ATXS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | -4830.6% | Higher Margin | MPLT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -111.5% | -43.1% | Higher ROE | ATXS |
| 52-Week Range Position Momentum | 3% ($6โ$40) | 93% ($4โ$13) | Stronger Trend | ATXS |
| Beta / 30D Volatility Risk Regime | 1.05ฮฒ ยท 78% Vol | 1.26ฮฒ ยท 20% Vol | Lower Realized Risk | ATXS |
| Unified Institutional Score Composite Signal | 50.4 / 100 (HOLD) | 57.0 / 100 (HOLD) | Higher Composite | ATXS |